Table 1 Baseline characteristics of the kidney transplant recipients
Characteristic | Cases (N = 66) | |
|---|---|---|
Recipients | ||
Age (years), mean ± SD | 42.50 ± 12.34 | |
Gender | ||
Female | 17 | (25.8) |
Male | 49 | (74.2) |
Length of stay (days), median (IQR) | 14 | (10–22.5) |
Cause of ESRD | ||
ADPKD | 1 | (1.5) |
CGN | 5 | (7.6) |
FSGS | 2 | (3.0) |
HT no biopsy | 1 | (1.5) |
IgA nephropathy | 1 | (1.5) |
LN/SLE biopsy proven | 3 | (4.5) |
Rt renal calculi with lt renal atrophy | 1 | (1.5) |
Suspicion of DKD | 2 | (3.0) |
Suspicion of VUR | 1 | (1.5) |
Unknown | 49 | (74.2) |
Transplant category | ||
DDKT | 47 | (71.2) |
LRKT | 19 | (28.8) |
Underlying disease | ||
HT | 50 | (75.8) |
DM | 6 | (9.1) |
DLP | 7 | (10.6) |
Other | 40 | (60.6) |
Clinical data | ||
Type of HD | ||
HD | 59 | (89.4) |
CAPD | 7 | (10.6) |
Time of HD (/weeks), median (IQR) | 3 | (2–3) |
Route of HD | ||
AVF | 45 | (68.2) |
AVBG | 8 | (12.1) |
TCC | 5 | (7.6) |
CAPD | 7 | (12.1) |
Dialysis vintage (years), median (IQR) | 4 | (2–7) |
Antibiotic within 6 months | 1 | (1.5) |
Admit within 6 months | 1 | (1.5) |
Induction | ||
IL2 | 48 | (72.7) |
ATG | 13 | (19.7) |
None | 5 | (7.6) |
Maintenance | ||
Tacrolimus/mycophenolate mofetil/corticosteroids | 62 | (93.9) |
Cyclosporine/mycophenolate mofetil/corticosteroids | 4 | (6.1) |
Operation time (min), mean ± SD | 244.74 ± 47.98 | |
Antibiotic prophylaxis | ||
Cefuroxime | 65 | (98.5) |
Clindamycin | 1 | (1.5) |
Ciprofloxacin | 1 | (1.5) |
Surgical complication | 31 | (47.0) |
Foley duration (days), median (IQR) | 7 | (6–8) |
Stent duration (days), median (IQR) | 15 | (13.75–17) |
Donor | ||
Age (years), mean ± SD | 41.35 ± 12.52 | |
Gender | ||
Female | 24 | (36.4) |
Male | 42 | (63.6) |
Donor urine culture | ||
Positivea | 6 | (9.1) |
NG | 30 | (45.5) |
Unknown | 30 | (45.5) |
Donor fever/infection | ||
No | 35 | (53.0) |
Yes | 31 | (47.0) |